Dewei Shang

1.6k total citations
83 papers, 1.2k citations indexed

About

Dewei Shang is a scholar working on Psychiatry and Mental health, Pharmacology and Molecular Biology. According to data from OpenAlex, Dewei Shang has authored 83 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Psychiatry and Mental health, 19 papers in Pharmacology and 17 papers in Molecular Biology. Recurrent topics in Dewei Shang's work include Schizophrenia research and treatment (17 papers), Bipolar Disorder and Treatment (17 papers) and Tryptophan and brain disorders (17 papers). Dewei Shang is often cited by papers focused on Schizophrenia research and treatment (17 papers), Bipolar Disorder and Treatment (17 papers) and Tryptophan and brain disorders (17 papers). Dewei Shang collaborates with scholars based in China, Canada and Macao. Dewei Shang's co-authors include Yuguan Wen, Jinqing Hu, Xiaojia Ni, Zhanzhang Wang, Haoyang Lu, Xiuqing Zhu, Ju Du, Yan Zhang, Qiang Zhang and Xue Ying and has published in prestigious journals such as Scientific Reports, Chemosphere and Journal of Controlled Release.

In The Last Decade

Dewei Shang

75 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dewei Shang China	17	416	260	230	182	154	83	1.2k
Joana Bicker Portugal	19	361 0.9×	98 0.4×	147 0.6×	41 0.2×	139 0.9×	53	1.3k
Szilvia Veszelka Hungary	30	687 1.7×	346 1.3×	63 0.3×	78 0.4×	80 0.5×	57	2.5k
Fruzsina R. Walter Hungary	25	511 1.2×	210 0.8×	53 0.2×	73 0.4×	67 0.4×	58	1.9k
Soyoung Lee South Korea	16	500 1.2×	45 0.2×	137 0.6×	56 0.3×	174 1.1×	23	1.3k
Thomas J. Abbruscato United States	32	1.2k 2.9×	102 0.4×	76 0.3×	83 0.5×	109 0.7×	81	2.8k
Gianluca Miglio Italy	25	850 2.0×	60 0.2×	76 0.3×	69 0.4×	123 0.8×	54	1.8k
László Tóthfalusi Hungary	25	306 0.7×	46 0.2×	115 0.5×	65 0.4×	132 0.9×	83	1.5k
Mads Kreilgaard Denmark	19	339 0.8×	43 0.2×	123 0.5×	65 0.4×	289 1.9×	49	1.9k
Ashif Iqubal India	23	544 1.3×	84 0.3×	36 0.2×	113 0.6×	148 1.0×	71	1.7k
Di Zhao China	27	816 2.0×	171 0.7×	24 0.1×	110 0.6×	227 1.5×	116	1.9k

Countries citing papers authored by Dewei Shang

Since Specialization

Citations

This map shows the geographic impact of Dewei Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewei Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewei Shang more than expected).

Fields of papers citing papers by Dewei Shang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dewei Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewei Shang. The network helps show where Dewei Shang may publish in the future.

Co-authorship network of co-authors of Dewei Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Dewei Shang. A scholar is included among the top collaborators of Dewei Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dewei Shang. Dewei Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Xingbing, Rui‐Hua Xu, Dewei Shang, et al.. (2025). Kynurenine pathway metabolites predict antianhedonic effects of electroconvulsive therapy in patients with treatment-resistant depression. Journal of Affective Disorders. 379. 764–771.

Xia, Hui, Gang Deng, Fanrong Liang, et al.. (2025). Investigating Remedial Strategies for Missed or Delayed Dose of Sertraline in Chinese Adolescent Patients with Depressive Disorders via Population Pharmacokinetics Modeling and Simulation Approaches. Drug Design Development and Therapy. Volume 19. 3001–3016.

Li, Xiaolin, Shanqing Huang, Shanshan Huang, et al.. (2025). Defining the therapeutic reference range and optimizing a high-dose discontinuation strategy for Paroxetine based on TDM and population pharmacokinetics. Journal of Pharmaceutical Sciences. 114(10). 103893–103893.

Xu, Zhilong, Haoyang Lu, Chen Hu, et al.. (2025). Inulin alleviates chronic ketamine-induced impairments in memory and prepulse inhibition by regulating the gut microbiota, inflammation, and kynurenine pathway. International Journal of Biological Macromolecules. 294. 139503–139503. 4 indexed citations

Zhang, Zi, et al.. (2024). MALDI-TOF MS-based SNP assay used to determine the appropriate antidepression for Chinese patients. Journal of Pharmaceutical and Biomedical Analysis. 252. 116460–116460. 1 indexed citations

Wang, Zhanzhang, et al.. (2024). Exploring the correlation between cardiovascular adverse events and antidepressant use: A retrospective pharmacovigilance analysis based on the FDA Adverse Event Reporting System database. Journal of Affective Disorders. 367. 96–108. 6 indexed citations

Wang, Zhanzhang, et al.. (2024). Effects of age, sex, daily dose, comorbidity and co‐medication on venlafaxine‐associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA Adverse Event Reporting System database. British Journal of Clinical Pharmacology.

Shang, Dewei, Shanqing Huang, Xin-Hu Yang, et al.. (2024). Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation in adolescents with first-episode major depressive disorder: A randomized, double-blind, sham-controlled pilot trial. Journal of Affective Disorders. 370. 190–197. 4 indexed citations

Huang, Xingbing, Dewei Shang, Xiong Huang, et al.. (2024). Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial. Journal of Affective Disorders. 368. 320–328. 5 indexed citations

10.

Zhang, Zi, Yaqian Tan, Lu Li, et al.. (2024). Population pharmacokinetic approach to guide personalized sertraline treatment in Chinese patients. Heliyon. 10(3). e25231–e25231. 3 indexed citations

11.

Lu, Haoyang, et al.. (2023). Development and validation of an LC-MS/MS method by one-step precipitation for cinacalcet in human plasma. Heliyon. 9(6). e17230–e17230. 3 indexed citations

12.

He, Jiahui, Dewei Shang, Zhanzhang Wang, Xiaofang Li, & Yuguan Wen. (2022). Physicians’ perceptions of generic drugs in China. PubMed. 3. 100067–100067. 4 indexed citations

13.

Liu, Shujing, Tao Xiao, Shanqing Huang, et al.. (2022). Population pharmacokinetics model for escitalopram in Chinese psychiatric patients: effect of CYP2C19 and age. Frontiers in Pharmacology. 13. 964758–964758. 6 indexed citations

14.

Yu, Lihua, Dewei Shang, Lulu Huang, et al.. (2022). Population pharmacokinetics of posaconazole in Chinese pediatric patients with acute leukaemia: Effect of food on bioavailability and dose optimization. European Journal of Pharmaceutical Sciences. 178. 106289–106289. 2 indexed citations

15.

Wang, Yang, Xiujuan Chen, Xiaoli Zhong, et al.. (2022). Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: A combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction. Frontiers in Pharmacology. 13. 942129–942129. 15 indexed citations

16.

Zhu, Xiuqing, Jinqing Hu, Tao Xiao, et al.. (2022). An interpretable stacking ensemble learning framework based on multi-dimensional data for real-time prediction of drug concentration: The example of olanzapine. Frontiers in Pharmacology. 13. 975855–975855. 17 indexed citations

17.

Zhu, Xiuqing, Jinqing Hu, Shuhua Deng, et al.. (2021). Comprehensive Bibliometric Analysis of the Kynurenine Pathway in Mood Disorders: Focus on Gut Microbiota Research. Frontiers in Pharmacology. 12. 687757–687757. 31 indexed citations

18.

Wang, Jiajia, Xiaofang Li, Lijun Hu, et al.. (2017). Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat. Journal of Ethnopharmacology. 214. 13–21. 40 indexed citations

19.

Hu, Jinqing, Dewei Shang, Xiaojia Ni, et al.. (2015). Effect of grapefruit juice and food on the pharmacokinetics of pirfenidone in healthy Chinese volunteers: a diet–drug interaction study. Xenobiotica. 46(6). 516–521. 11 indexed citations

20.

Li, Lijun, Dewei Shang, Wen-Biao Li, et al.. (2012). Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia. Acta Pharmacologica Sinica. 33(11). 1409–1416. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact